BRX enters its Q1 2026 earnings release today with short sellers notably less committed than they were a month ago. Short interest dropped nearly 9.5% in a single week to 4.7% of the free float — a meaningful pullback from the spike above 5.8% seen in early April. Utilization is running at just 2.3%, well below the 52-week peak of 6.4%, and borrow costs have eased sharply to 0.35%. That combination signals a low-friction short market with little conviction behind the bearish trade.
Options positioning is slightly more guarded than the recent norm, though far from alarmed. The put/call ratio has climbed to 0.26 — above its 20-day average of 0.19 but less than one standard deviation from the mean. For context, the 52-week high is 0.41, so today's reading is nowhere near peak defensiveness. The stock has added 7.5% over the past month to $30.50, with only a modest 1.5% pullback on the week. Most close peers — KIM, KRG, REG, and FRT — fell between 0.9% and 2.8% over the same week, making BRX's relative resilience notable in a sector that broadly softened.
The Street has been quietly constructive, though the most recent analyst activity is about five weeks old. Multiple firms raised price targets into the $32–$34 range in the February–March window, with JPMorgan lifting its Overweight target to $33 and Piper Sandler taking the highest position at $34. The mean target of $32.21 implies roughly 6% upside from the current price — a modest premium that suggests the Street sees the stock as fairly rather than cheaply priced. EPS momentum ranks in the 80th percentile on a 90-day basis, and the company scores in the 85th percentile on earnings surprise history, pointing to a consistent pattern of beating estimates.
The insider picture is quiet. Recent trades from February were predominantly routine award-related sells from the COO and CIO at around $27.73 — well below the current price — and net insider activity over 90 days reflects a positive share balance, though the dollar amounts are modest and the significance scores low. Institutional ownership is stable and heavily index-driven, with Vanguard and BlackRock together holding over 27% of shares; CenterSquare added over two million shares in Q1, the largest incremental move among top holders.
The Q1 print will test whether the operating performance that drove consecutive estimate beats — and drew broad target upgrades across the sector — holds up against a more uncertain consumer backdrop, and whether same-store NOI growth can sustain the valuation re-rating that pushed the stock up nearly 7.5% in a month.
See the live data behind this article on ORTEX.
Open BRX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
